Are Wall Street Analysts Bullish on Solventum Stock? Solventum has underperformed the broader market, while analysts remain moderately optimistic about its future prospects. Barchart · Aug 14
Solventum Nears Inflection Point As It Begins to Unlock Value Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers. MarketBeat · Aug 7
Solventum’s Q2 2026 Earnings: What to Expect Solventum is scheduled to report its fiscal second-quarter results early next month, with analysts expecting a modest year-over-year increase in earnings. Barchart · Jul 22
Solventum Stock: Is SOLV Underperforming the Healthcare Sector? The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw. Barchart · Jun 22
Solventum Earnings Preview: What to Expect Solventum will release its first-quarter earnings next month, and analysts anticipate a marginal bottom-line growth. Barchart · Apr 23
Solventum Stock: Is Wall Street Bullish or Bearish? Solventum has lagged behind the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects. Barchart · Feb 11
What You Need To Know Ahead of Solventum Earnings Release Solventum is expected to release its fiscal fourth-quarter earnings soon, and analysts project a modest earnings increase. Barchart · Jan 22
Protect your agentic AI before you wreck your agentic AI On the nuances of agentic AI-driven change management during the 2026 Fortune Brainstorm Tech dinner during CES in Las Vegas. Fortune · Jan 16
Is Solventum Stock Outperforming the Nasdaq? Solventum has delivered stronger performance than the Nasdaq Composite over the past year, reinforcing analysts’ moderate optimism regarding the stock’s forward outlook. Barchart · Dec 16, 2025
Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity Check out these three stocks that are up more than 20% in 2025 and just increased their buyback capacity. One stock experiencing strong growth stands out. MarketBeat · Dec 1, 2025
Solventum Stock: Analyst Estimates & Ratings Solventum has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects. Barchart · Nov 13, 2025
What to Expect From Solventum's Next Quarterly Earnings Report Solventum will release its third-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth. Barchart · Oct 24, 2025
Do Wall Street Analysts Like Solventum Stock? Although Solventum has outperformed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Aug 18, 2025
What to Expect From Solventum's Q2 2025 Earnings Report Solventum will release its second-quarter earnings next month, and analysts anticipate a single-digit profit dip. Barchart · Jul 24, 2025
Barchart · Jun 25, 2025 How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? Solventum has outperformed relative to its healthcare equipment peers over the past year, but Wall Street analysts maintain a skeptical view on the stock’s outlook.
Barchart · May 16, 2025 Solventum Stock Outlook: Is Wall Street Bullish or Bearish? Solventum has outperformed the broader market over the past year, yet analysts remain cautious about the stock’s prospects.
Barchart · Apr 28, 2025 Here's What to Expect From Solventum’s Next Earnings Report Solventum is expected to unveil its first quarter results in the upcoming month, and analysts predict its bottom line to suffer in double digits.
Barchart · Apr 2, 2025 Solventum Stock: Is SOLV Outperforming the Healthcare Sector? Despite outpacing the healthcare sector over the past year, analysts remain cautious about the stock’s prospects.
Barchart · Feb 17, 2025 Are Wall Street Analysts Predicting Solventum Stock Will Climb or Sink? Although Solventum has outperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's growth potential.
Barchart · Jan 20, 2025 Earnings Preview: What to Expect from Solventum’s Report Recently spun-off healthcare major Solventum is expected to announce its fourth-quarter results in the upcoming month and analysts predict an EPS of $1.31.
Barchart · Dec 30, 2024 Is Solventum Stock Underperforming the Dow? Solventum has underperformed compared to the Dow index over the past three months, though analysts remain cautious about the stock’s growth prospects.
Benzinga · Dec 4, 2024 A Peek at Cooper Companies's Future Earnings Cooper Companies (NYSE:COO) is gearing up to announce its quarterly earnings on Thursday, 2024-12-05. Here's a quick overview of what investors should know before the release.
Benzinga · Dec 4, 2024 5 Analysts Have This To Say About Solventum In the preceding three months, 5 analysts have released ratings for Solventum (NYSE:SOLV), presenting a wide array of perspectives from bullish to bearish.
Barchart · Nov 20, 2024 Is Wall Street Bullish or Bearish on Solventum Stock? Due to Solventum’s underperformance relative to the broader S&P 500 Index over the past six months, Wall Street analysts remain cautious about the stock’s prospects.
Barchart · Oct 29, 2024 Solventum's Quarterly Earnings Preview: What You Need to Know Solventum is scheduled to report its third-quarter results next month.